Main efficacy indicators | Secondary efficacy measurements |
---|---|
6MWD HRR1 | Pulmonary hypertension WHO classification Borg Dyspnea Score Minnesota Living with Heart Failure Questionnaire NT-proBNP cTNI RVSP Uric acid Volume of pericardial effusion Pulmonary artery diameter Diameter of the same layer of aorta Arterial oxygen saturation Time of clinical deterioration |